By Danny Foody, Project Farma
Determining the right technical operations (tech ops) strategy for a precision medicine or emerging biopharma company can feel like building a complex piece of machinery from scratch without instructions. It’s intricate, multifaceted, and requires flexible design and approach. The components include establishing a physical footprint, development of quality management systems to mitigate chemistry, manufacturing, and controls (CMC) bottlenecks; navigating an evolving supply chain landscape; and recruiting top talent commensurate to internal and external throughput. Piecing these different mechanisms into a phased and executable plan requires a customized solution based on your company’s process and a set of well-defined long term strategic goals and growth stage.
Key Drivers To Develop Your Tech Ops Strategy
Early-stage and emerging companies are rapidly populating the biopharmaceutical industry, making swiftly evolving therapeutic breakthroughs. The long road that begins with translating scientific discoveries, winds through CMC scale-up, and ultimately leads to patients is highly competitive, with multiple chokepoints and increasingly elusive capital funding opportunities. A quantitative and qualitative tech ops strategy is crucial for companies to launch their journey with a sound roadmap while attracting investors.